1. Home
  2. STRR vs CNSP Comparison

STRR vs CNSP Comparison

Compare STRR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRR
  • CNSP
  • Stock Information
  • Founded
  • STRR 1985
  • CNSP 2017
  • Country
  • STRR United States
  • CNSP United States
  • Employees
  • STRR N/A
  • CNSP N/A
  • Industry
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRR Health Care
  • CNSP Health Care
  • Exchange
  • STRR Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • STRR 6.3M
  • CNSP 5.6M
  • IPO Year
  • STRR N/A
  • CNSP 2019
  • Fundamental
  • Price
  • STRR $2.13
  • CNSP $1.04
  • Analyst Decision
  • STRR Strong Buy
  • CNSP Hold
  • Analyst Count
  • STRR 1
  • CNSP 1
  • Target Price
  • STRR $5.00
  • CNSP N/A
  • AVG Volume (30 Days)
  • STRR 61.6K
  • CNSP 4.9M
  • Earning Date
  • STRR 05-14-2025
  • CNSP 06-17-2025
  • Dividend Yield
  • STRR N/A
  • CNSP N/A
  • EPS Growth
  • STRR N/A
  • CNSP N/A
  • EPS
  • STRR N/A
  • CNSP N/A
  • Revenue
  • STRR $57,165,000.00
  • CNSP N/A
  • Revenue This Year
  • STRR $33.64
  • CNSP N/A
  • Revenue Next Year
  • STRR $22.87
  • CNSP N/A
  • P/E Ratio
  • STRR N/A
  • CNSP N/A
  • Revenue Growth
  • STRR 34.33
  • CNSP N/A
  • 52 Week Low
  • STRR $1.72
  • CNSP $0.77
  • 52 Week High
  • STRR $5.35
  • CNSP $414.00
  • Technical
  • Relative Strength Index (RSI)
  • STRR 47.17
  • CNSP 42.18
  • Support Level
  • STRR $2.16
  • CNSP $1.00
  • Resistance Level
  • STRR $2.75
  • CNSP $1.08
  • Average True Range (ATR)
  • STRR 0.24
  • CNSP 0.09
  • MACD
  • STRR -0.00
  • CNSP 0.00
  • Stochastic Oscillator
  • STRR 32.80
  • CNSP 19.05

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: